bioRxivBioinformaticsPreprint
Literature-based predictions of treatments for genetic disease pathology
Cole A. DeisserothiD, Won‐Seok LeeiD, Ji‐Yoen Kim, Hyun-Hwan JeongiD, Julia WangiD, Huda Yahya ZoghbiiD, Zhandong LiuiD
Abstract
Identifying genetic modifiers of disease-causing genes can guide drug discovery for treatment of genetic disorders, but selecting promising drugs to test requires extensive and up-to-date knowledge of drug-gene and gene-gene relationships. To address this challenge, we present PARsing ModifiErS via Abstract aNnotations (PARMESAN), a computational tool that searches PubMed for information on these relationships, and assembles them into one knowledgebase. PARMESAN then hypothesizes on undiscovered drug-gene relationships, assigning an evidence-based score to each hypothesis. We compare PARMESANs drug-gene hypotheses to all of the drug-gene relationships displayed by DrugBank, and see a strong correlation between the prediction score and the predictive accuracy--such that predictions scoring above 10 are 11 times more likely to be correct than incorrect. This publicly available tool provides an automated way to prioritize drug screens to target the most-promising drugs to test, thereby saving time and resources in the development of therapeutics for genetic disorders.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic similarity among 178 disease phenotypes predicts therapeutic and side effects for 1,711 drugs
Panagiotis Nikolaos Lalagkas, Rachel Melamed·medRxiv·May 13, 2025
- Integration of genetic evidence to identify approved drug targets
Samuel Moix, Marie C. Sadler, Zoltán Kutalik·Genome MedicinePeer-reviewed·Jul 6, 2026
- PEMT: A patent enrichment tool for drug discovery
Yojana Gadiya, Andrea Zaliani, … Martin Hofmann‐Apitius·BioinformaticsPeer-reviewed·Nov 1, 2022
- Drug Gene-Set Analysis Identifies Established and Emerging Therapeutic Mechanisms
Nathaniel Y. Bell, Emil Uffelmann, … Daniëlle Posthuma·medRxiv·Sep 6, 2022
- Prioritizing Parkinson's disease risk genes in genome-wide association loci
Lara Mariah Lange, Catalina Cerquera‐Cleves, … Karl Heilbron·npj Parkinson s DiseasePeer-reviewed·Apr 16, 2025
- Mapping drug biology to disease genetics to discover drug impacts on the human phenome
Mamoon Habib, Panagiotis Nikolaos Lalagkas, Rachel Melamed·Bioinformatics AdvancesPeer-reviewed·Jan 1, 2024